Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
- Jordà, Paloma
- Bosman, Laurens P
- Gasperetti, Alessio
- Mazzanti, Andrea
- Gourraud, Jean Baptiste
- Davies, Brianna
- Frederiksen, Tanja Charlotte
- Moreno Weidmann, Zoraida
- Di Marco, Andrea
- Roberts, Jason D
- MacIntyre, Ciorsti
- Seifer, Colette
- Delinière, Antoine
- Alqarawi, Wael
- Kukavica, Deni
- Minois, Damien
- Trancuccio, Alessandro
- Arnaud, Marine
- Targetti, Mattia
- Martino, Annamaria
- Oliviero, Giada
- Pipilas, Daniel C
- Carbucicchio, Corrado
- Compagnucci, Paolo
- Dello Russo, Antonio
- Olivotto, Iacopo
- Calò, Leonardo
- Lubitz, Steven A
- Cutler, Michael J
- Chevalier, Philippe
- Arbelo, Elena
- Priori, Silvia Giuliana
- Healey, Jeffrey S
- Calkins, Hugh
- Casella, Michela
- Jensen, Henrik Kjærulf
- Tondo, Claudio
- Tadros, Rafik
- James, Cynthia A
- Krahn, Andrew D
- Cadrin-Tourigny, Julia
Publication date
January 2022
DOIAbstract
Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes ventricular arrhythmias (VAs) and sudden cardiac death (SCD). In 2019, a risk prediction model that estimates the 5-year risk of incident VAs in ARVC was developed (ARVCrisk.com). This study aimed to externally validate this prediction model in a large international multicentre cohort and to compare its performance with the risk factor approach recommended for implantable cardioverter-defibrillator (ICD) use by published guidelines and expert consensus
Add to ORKG